Pharmacytimes http://www.pharmacytimes.com/rss PharmacyTimes.com offers continuing education (CE) courses, career guidance for pharmacy students, online-only articles, digital versions of the print issue, and more, that are essential to pharmacists en-us Thu, 21 Feb 19 00:05:21 +0000 Thu, 21 Feb 19 00:05:21 +0000 Respiratory Inhaler for Delivering Cannabinoids Receives ISO Certification http://www.pharmacytimes.com/news/respiratory-inhaler-for-delivering-cannabinoids-receives-iso-certification http://www.pharmacytimes.com/news/respiratory-inhaler-for-delivering-cannabinoids-receives-iso-certification A Senzer medical device for delivering pharmaceutical-grade cannabinoids has been granted ISO certification for Design and Development. Wed, 20 Feb 19 15:00:00 +0000 Intranasal Epinephrine Spray Granted Fast Track Designation http://www.pharmacytimes.com/news/intranasal-epinephrine-spray-granted-fast-track-designation http://www.pharmacytimes.com/news/intranasal-epinephrine-spray-granted-fast-track-designation The needed-free treatment option, ARS-1, is designed to be easy-to-use, convenient and more reliable than other emergency epinephrine treatments for severe allergic reactions. Wed, 20 Feb 19 15:00:00 +0000 New Treatment for Hemophilia A Receives FDA Approval http://www.pharmacytimes.com/news/new-treatment-for-hemophilia-a-receives-fda-approval http://www.pharmacytimes.com/news/new-treatment-for-hemophilia-a-receives-fda-approval The FDA has approved the Biologics License Application for Novo Nordisk&rsquo;s long-acting factor VIII replacement treatment for adults and children with hemophilia A. Tue, 19 Feb 19 18:38:00 +0000 Pembrolizumab Granted FDA Approval for Adjuvant Treatment of Stage 3 Melanoma http://www.pharmacytimes.com/news/pembrolizumab-granted-fda-approval-for-adjuvant-treatment-of-stage-3-melanoma http://www.pharmacytimes.com/news/pembrolizumab-granted-fda-approval-for-adjuvant-treatment-of-stage-3-melanoma Officials with the FDA have granted approval to Merck&rsquo;s pembrolizumab (Keytruda) for the adjuvant treatment of melanoma with involvement of lymph node(s) following complete resection. Tue, 19 Feb 19 16:05:00 +0000 FDA Approves Premixed Vancomycin Injection http://www.pharmacytimes.com/news/fda-approves-premixed-vancomycin-injection http://www.pharmacytimes.com/news/fda-approves-premixed-vancomycin-injection Officials with the FDA have approved Xellia Pharmaceuticals&rsquo; Premixed Vancomycin Injection in a Ready-to-Use (RTU) bag, according to the company. Tue, 19 Feb 19 15:34:00 +0000 Pembrolizumab, Axitinib Combo for Advanced Kidney Cancer Granted Priority Review Designation http://www.pharmacytimes.com/news/pembrolizumab-axitinib-combo-for-advanced-kidney-cancer-granted-priority-review-designation http://www.pharmacytimes.com/news/pembrolizumab-axitinib-combo-for-advanced-kidney-cancer-granted-priority-review-designation Officials with the FDA have granted Priority Review to Merck&rsquo;s supplemental Biologics License Application (sBLA) for pembrolizumab (Keytruda) for use in combination with axitinib (Inlyta, Pfizer) as first-line treatment for advanced renal cell carcinoma (RCC). Mon, 18 Feb 19 12:00:00 +0000 Study: Drug Therapy Reduced Rate of Decline in Children with CLN2 http://www.pharmacytimes.com/news/study-drug-therapy-reduced-rate-of-decline-in-children-with-cln2- http://www.pharmacytimes.com/news/study-drug-therapy-reduced-rate-of-decline-in-children-with-cln2- The study was aimed at the efficacy and safety of cerliponase alfa (Brineura, BioMarin) for patients with CLN2. Fri, 15 Feb 19 16:20:00 +0000 Digital Partnership Offers Compliant Patient Communications http://www.pharmacytimes.com/news/digital-partnership-offers-compliant-patient-communications http://www.pharmacytimes.com/news/digital-partnership-offers-compliant-patient-communications QS/1, a health care software solutions company, is partnering with Digital Pharmacist, Inc. to offer secure, HIPAA-compliant methods of patient communication through a variety of platforms. Fri, 15 Feb 19 12:00:00 +0000 FDA Approves Treatment for Neglected Tropical Disease http://www.pharmacytimes.com/news/fda-approves-treatment-for-neglected-tropical-disease http://www.pharmacytimes.com/news/fda-approves-treatment-for-neglected-tropical-disease Officials with the FDA have approved Novartis&rsquo; triclabendazole (Egaten) for the treatment of fascioliasis, also known as liver fluke infestation, in patients age 6 years and older. Wed, 13 Feb 19 23:00:00 +0000 Former House Speaker Scheduled to Speak at NACDS Meeting http://www.pharmacytimes.com/news/former-house-speaker-slated-to-speak-at-nacds-meeting http://www.pharmacytimes.com/news/former-house-speaker-slated-to-speak-at-nacds-meeting Ryan, who was elected as the 54th Speaker of the House in 2015 and served in that role until January 2019 will speak as part of the Business Program, scheduled for Tuesday April 30. Wed, 13 Feb 19 20:42:00 +0000 New FDA Program Aims to Improve Quality, Innovation in Drug Development http://www.pharmacytimes.com/news/new-fda-program-aims-to-improve-quality-innovation-in-drug-development http://www.pharmacytimes.com/news/new-fda-program-aims-to-improve-quality-innovation-in-drug-development An FDA program is seeking to facilitate better quality drug manufacturing through recognized consensus standards. Wed, 13 Feb 19 17:49:00 +0000 FDA Officials OK Generic Overactive Bladder Treatment http://www.pharmacytimes.com/news/fda-officials-ok-generic-overactive-bladder-treatment- http://www.pharmacytimes.com/news/fda-officials-ok-generic-overactive-bladder-treatment- Camber recently announced the FDA approval of Tolterodine Tartrate ER capsules, a generic version of Detrol LA (tolterodine, Pharmacia &amp; Upjohn). Wed, 13 Feb 19 11:00:00 +0000 Split-Dosing Regimen Granted FDA Approval for Multiple Myeloma Treatment http://www.pharmacytimes.com/news/splitdosing-regimen-granted-fda-approval-for-multiple-myeloma-treatment- http://www.pharmacytimes.com/news/splitdosing-regimen-granted-fda-approval-for-multiple-myeloma-treatment- Daratumumab was first approved in November 2015 as the first and only CD38-directed antibody for the treatment of patients with multiple myeloma who have received at least 3 prior lines of therapy, including a proteasome inhibitor (PI) and an immunomodulatory agent, or who are double refractory to both.&nbsp; Tue, 12 Feb 19 16:00:00 +0000 Pharmacists Are Happy With Their Salaries, Less So With Their Jobs, Survey Shows (Part 2) http://www.pharmacytimes.com/news/pharmacists-are-happy-with-their-salaries-less-so-with-their-jobs-survey-shows-part-2 http://www.pharmacytimes.com/news/pharmacists-are-happy-with-their-salaries-less-so-with-their-jobs-survey-shows-part-2 Although many pharmacists are divided when it comes to their job satisfaction, most of them are currently happy with their compensation, according to a recent <em>Pharmacy Times<sup>&reg;</sup></em> Salary and Job Satisfaction Survey. Tue, 12 Feb 19 13:00:00 +0000 Companies Reduce List Price for High Cholesterol Therapy http://www.pharmacytimes.com/news/companies-reduce-list-price-for-high-cholesterol-therapy http://www.pharmacytimes.com/news/companies-reduce-list-price-for-high-cholesterol-therapy The collaborating drug companies cut prices in an effort to make their drugs more accessible.&nbsp;<br /> &nbsp; Mon, 11 Feb 19 23:00:00 +0000 FDA Takes Action Against 17 Companies Claiming to Treat Serious Diseases http://www.pharmacytimes.com/news/fda-takes-action-against-17-companies-claiming-to-treat-serious-diseases http://www.pharmacytimes.com/news/fda-takes-action-against-17-companies-claiming-to-treat-serious-diseases Warning letters and online advisory letters were posted to the agency&#39;s website for 58 products, mostly dietary supplements. Mon, 11 Feb 19 19:00:00 +0000 Researchers Predict Opioid Epidemic Will Grow http://www.pharmacytimes.com/news/researchers-predict-opioid-epidemic-will-grow- http://www.pharmacytimes.com/news/researchers-predict-opioid-epidemic-will-grow- Researchers&nbsp;predict that the changing nature of the epidemic, driven by the illegal use of opioids such as heroin and fentanyl, has reduced the potential impact of programs that target prescription opioids. Sun, 10 Feb 19 17:00:00 +0000 FDA Launches New Track-and-Trace Pilot Program http://www.pharmacytimes.com/news/fda-launches-new-trackandtrace-pilot-program http://www.pharmacytimes.com/news/fda-launches-new-trackandtrace-pilot-program The program aims to reduce the amount of illegal or suspect prescription drugs distributed throughout the United States. Fri, 08 Feb 19 17:11:00 +0000 Directions in Pharmacy Meetings Announced for Spring 2019 http://www.pharmacytimes.com/news/directions-in-pharmacy-meetings-announced-for-spring-2019 http://www.pharmacytimes.com/news/directions-in-pharmacy-meetings-announced-for-spring-2019 <em>Pharmacy Times&nbsp;Continuing Education</em>&trade; (PTCE), a leader in continuing education for retail, health-system, managed care and specialty pharmacists, has announced the ninth annual Directions in Pharmacy&reg;&nbsp;continuing education conference series, which will take place in 4 major cities across the United States in spring 2019. Fri, 08 Feb 19 03:50:00 +0000 Study Predicts Virtual Care to Expand in Upcoming Year http://www.pharmacytimes.com/news/study-predicts-virtual-care-to-expand-in-upcoming-year http://www.pharmacytimes.com/news/study-predicts-virtual-care-to-expand-in-upcoming-year A recent study analyzed how health systems utilize and integrate virtual care into their daily practice. Thu, 07 Feb 19 18:00:00 +0000 First Therapy Indicated for Rare Blood Clotting Disorder Granted FDA Approval http://www.pharmacytimes.com/news/first-therapy-indicated-for-rare-blood-clotting-disorder-granted-fda-approval http://www.pharmacytimes.com/news/first-therapy-indicated-for-rare-blood-clotting-disorder-granted-fda-approval Officials with the FDA have approved caplacizumab-yhdp (Cablivi, Sanofi) injection for the treatment of adults with acquired thrombotic thrombocytopenic purpura (aTTP), a rare and life-threatening blood clotting autoimmune disorder. &nbsp; Wed, 06 Feb 19 19:34:00 +0000 Regulatory Review Filings for 2 Antibacterial Agents Accepted by FDA http://www.pharmacytimes.com/news/regulatory-review-filings-for-2-antibacterial-agents-accepted-by-fda http://www.pharmacytimes.com/news/regulatory-review-filings-for-2-antibacterial-agents-accepted-by-fda A New Drug Application (NDA) and a supplemental NDA (sNDA) were accepted for the Priority Review for products being developed by Merck. Tue, 05 Feb 19 17:00:00 +0000 Recall Continuing for Seizure Treatment Drug http://www.pharmacytimes.com/news/recall-continuing-for-epilepsy-treatment-drug http://www.pharmacytimes.com/news/recall-continuing-for-epilepsy-treatment-drug Dr. Reddy&rsquo;s Laboratories is continuing its voluntary nationwide recall of the antiepileptic drug Levetiracetram in 0.54% Sodium Chloride Injection, 1,500 mg/100 mL (15 mg/mL) in single-dose infusion bags to the hospital level in the United States. Tue, 05 Feb 19 01:00:00 +0000 FDA Issues New Warning About Warfarin Test Strips http://www.pharmacytimes.com/news/fda-issues-new-warning-about-warfarin-test-strips http://www.pharmacytimes.com/news/fda-issues-new-warning-about-warfarin-test-strips The FDA is warning patients and doctors that certain test strips used to monitor levels of the blood thinner warfarin may provide inaccurate results and should not be relied upon to adjust the drug dosage. Fri, 01 Feb 19 22:44:00 +0000 FDA Expands Drug's Label With Combo Therapy for First-Line NSCLC Treatment http://www.pharmacytimes.com/news/fda-expands-drugs-label-with-combo-therapy-for-firstline-nsclc-treatment http://www.pharmacytimes.com/news/fda-expands-drugs-label-with-combo-therapy-for-firstline-nsclc-treatment Officials with the FDA have expanded the label of pemetrexed for injection (Alimta, Eli Lilly) in combination with pembrolizumab (Keytruda, Merck) and platinum chemotherapy. Fri, 01 Feb 19 17:00:00 +0000